logo

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Glenn F Reynolds

This inventor holds 8 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1988-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glenn F Reynolds. Retrieved from https://idiyas.com/inventor/glenn-f-reynolds

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 270(Granted Patents)


Company Filing History:

goldMedal8 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1988-1996

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5571817 - Methods of treating androgenic alopecia with finasteride (1996-11-05),
2. 5567708 - Methods of treating androgenic alopecia with finasteride (1996-10-22),
3. 5151429 - 17.beta.-acyl-4-aza-5.alpha.-androst-1-ene-3-ones as 5.alpha. reductase (1992-09-29),
4. 5138063 - 17.beta.-methoxycarbonyl-4-aza-androsten-1-en-3-ones (1992-08-11),
5. 5120742 - 17 .beta.-acyl-4-aza-5 .alpha.-androst-1-ene-3-ones as 5 (1992-06-09),
6. 5049562 - 17.beta.-acyl-4-aza-5.alpha.-androst-1-ene-3-ones as 5.alpha.-reductase (1991-09-17),
7. 4859681 - 17 .alpha.-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase (1989-08-22),
8. 4760071 - 17.beta.-N-monosubstituted carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones (1988-07-26),

Title: Glenn F. Reynolds: Innovator in Androgenic Alopecia Treatments

Introduction

Glenn F. Reynolds is a notable inventor based in Westfield, NJ (US), recognized for his contributions to the field of medical treatments, particularly in addressing androgenic alopecia. With a total of 8 patents to his name, Reynolds has made significant strides in developing innovative solutions for hair loss.

Latest Patents

Reynolds' latest patents focus on methods of treating androgenic alopecia using finasteride. His work involves 17.beta.-N-monosubstituted-carbamoyl-4-5.alpha.-androst-1-en-3-ones, which are designed to act as testosterone 5.alpha.-reductase inhibitors. These compounds are useful topically for the treatment of androgenic alopecia, showcasing Reynolds' commitment to advancing medical treatments.

Career Highlights

Throughout his career, Glenn F. Reynolds has been associated with Merck & Company, Inc., where he has contributed to various research initiatives. His expertise in pharmacology and innovative thinking has led to the development of effective treatments that address significant health concerns.

Collaborations

Reynolds has collaborated with Gary H. Rasmusson, further enhancing the research and development of treatments for androgenic alopecia. Their partnership exemplifies the importance of teamwork in the field of medical innovation.

Conclusion

Glenn F. Reynolds stands out as a prominent inventor in the realm of medical treatments for hair loss. His innovative patents and collaborations reflect his dedication to improving the lives of those affected by androgenic alopecia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…